
A jab aimed at reducing thousands of deaths and hospital admissions among the elderly has been approved for use in the UK.
Regulators have given the green light for the first respiratory syncytial virus (RSV) vaccine for older adults.

A jab aimed at reducing thousands of deaths and hospital admissions among the elderly has been approved for use in the UK.
Regulators have given the green light for the first respiratory syncytial virus (RSV) vaccine for older adults.